Published in
Elsevier, European Journal of Cancer, (173), p. 167-177, 2022
DOI: 10.1016/j.ejca.2022.06.045
Links
Tools
Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials
Journal article published in 2022 by
Abdulazeez Salawu 
,
Alberto Hernando-Calvo ,
Rachel Y. Chen ,
Daniel V. Araujo ,
Marc Oliva ,
Zhihui A. Liu,
Lillian L. Siu
,
Alberto Hernando-Calvo ,
Rachel Y. Chen ,
Daniel V. Araujo ,
Marc Oliva ,
Zhihui A. Liu,
Lillian L. Siu
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 